MedTrace Logo

Orchestra Pregnancy Observational Study in Poland

NCT01779141 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 481

Last updated 2020-02-05

Study results available
· View outcomes & findings →

Summary

The aim of this project is to document the use of insulin pump therapy (CSII), including sensor augmented pump therapy (SAP), before, during and after pregnancy in women with type 1 Diabetes Mellitus benefiting from the Orchestra donation of Paradigm REAL-Time and Paradigm Veo pumps in Poland.

Conditions

  • Type 1 Diabetes Mellitus
  • Pregnancy

Sponsors & Collaborators

  • Medtronic Poland Spółka z ograniczoną odpowiedzialnością

    collaborator INDUSTRY

  • Medtronic Diabetes

    lead INDUSTRY

Principal Investigators

  • Jacek Sieradzki, Prof · Cracow Medical University

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01779141 on ClinicalTrials.gov